Fibers & textiles
Biotechnology in textiles
The cross-cutting constraint on biological routes into textiles: commodity fibre prices set a cost ceiling that fermentation must meet, which is why enzymes arrived first and grown materials remain at the premium end.
This page covers what the individual routes have in common; the mechanisms themselves belong to their own pages — mycelium and plant sheets, recombinant collagen and silk, microbial dyeing, enzymatic recycling and tanning.
Textiles are an unusually hostile market for biotechnology, and the reason is arithmetic rather than science. Commodity polyester lands near one to two dollars a kilogram and cotton not far above it, at megatonne scale. A fermentation process pays for a sterile vessel, a defined medium, oxygen transfer, and downstream recovery of a dilute product from water. That cost floor sits well above commodity fibre, and no amount of strain engineering moves it by the order of magnitude the comparison demands. Every successful application so far has resolved this in one of two ways: enter where the biological step is catalytic and consumed in grams, or accept a premium position where the buyer is not comparing against commodity fibre at all.
Why enzymes arrived first
Enzymes take the first route and were in mills decades before anything was grown. An enzyme is a catalyst, dosed at fractions of a percent on fabric weight, and it displaces a process rather than a material. Desizing with amylases, bio-scouring with pectinases, cellulase biopolishing and denim biostoning all replace harsh chemical or mechanical steps whose costs — alkali, energy for hot alkaline baths, effluent load, pumice and the fabric it destroys — are themselves substantial. The economics work because the enzyme is compared against a chemical process, not against a fibre. The same logic explains why enzymatic recycling of polyester is a credible industrial proposition while growing polyester is not.
Why grown materials sit at the premium end
The second route sells into applications where fibre price is a minor term. A mycelium panel or a recombinant protein fibre competes with calfskin, exotic leather or high-performance technical textiles, where the incumbent is expensive, supply is constrained, and provenance carries a price. This is not a transitional stage that scale will resolve on its own: the cost floor is set by the bioprocess, and only a step change in titre, in feedstock, or in a fermentation-free route alters it.
The property gap, stated honestly
Biology also has to meet the properties. Textile fibres are asked for tensile strength, elastic recovery, abrasion resistance, wet strength, dyeability and dimensional stability over hundreds of laundering cycles — a specification refined against synthetic polymers for seventy years. Protein and fungal materials frequently meet some of these and fail others, and the failures cluster in durability rather than in initial performance, which is precisely what a short wear trial does not reveal.
The consequence for reading this field: a claim about a bio-based textile should be checked for which of the two routes it belongs to, and against what incumbent it is being priced.